| SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549 |
SCHEDULE 13G |
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment
No. 9
)*
|
CardioGenics Holdings Inc. (Name of Issuer) |
Common Stock $0.00001 par value (Title of Class of Securities) |
14160X203 (CUSIP Number) |
03/11/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule
13d-1(b) |
 Rule
13d-1(c) |
| Rule
13d-1(d) |
SCHEDULE 13G |
| CUSIP No. | 14160X203 |
| 1 | Names of Reporting Persons Iliad Research & Trading, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization UTAH | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 2,415,275.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 9.9 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) PN |
Comment for Type of Reporting Person:
Reporting Person Iliad Research & Trading, LP ("Iliad") has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).
SCHEDULE 13G |
| CUSIP No. | 14160X203 |
| 1 | Names of Reporting Persons Iliad Management, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 2,415,275.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 9.9 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) OO |
Comment for Type of Reporting Person:
Iliad Management, LLC is the general partner of reporting person Iliad. Iliad has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).
SCHEDULE 13G |
| CUSIP No. | 14160X203 |
| 1 | Names of Reporting Persons Fife Trading, Inc. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization ILLINOIS | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 2,415,275.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 9.9 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) CO |
Comment for Type of Reporting Person:
Fife Trading, Inc. is the manager of Iliad Management, LLC, which is the general partner of reporting person Iliad. Iliad has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).
SCHEDULE 13G |
| CUSIP No. | 14160X203 |
| 1 | Names of Reporting Persons John M Fife | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization UNITED STATES | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 2,415,275.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 9.9 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) IN |
Comment for Type of Reporting Person:
John Fife is the president of Fife Trading, Inc. which is the manager of Iliad Management, LLC, which is the general partner of reporting person Iliad. Iliad has rights to convert a Promissory Note into shares of the Issuer's common stock. On the date of the event which requires filing this statement, the number of shares of the Issuer's common stock beneficially owned by Iliad was 2,415,275 shares, which represents the maximum percentage ownership allowed under the terms of the Secured Convertible Promissory Note in effect on that date. The 2,415,275 shares represent 9.99% of the 24,176,927 shares outstanding on that date (as reported in the Issuer's Form 10-Q filed March 24, 2015).
SCHEDULE 13G |
| Item 1. | ||
| (a) | Name of issuer: CardioGenics Holdings Inc. | |
| (b) | Address of issuer's principal executive
offices: 6865 SW 18TH STREET SUITE B13, BACA RATON, FLORIDA, 33433 | |
| Item 2. | ||
| (a) | Name of person filing: This report is filed by Iliad Research and Trading, LP, Iliad Management, LLC, Fife Trading, Inc., and John M. Fife with respect to the shares of Common Stock, $0.00001 par value per share, of the Issuer that are directly beneficially owned by Iliad Research and Trading, LP and indirectly beneficially owned by the other reporting and filing persons. | |
| (b) | Address or principal business office or, if
none, residence: The address of the principal business office of each reporting and filing person is:
303 East Wacker Drive, Suite 1040,
Chicago, IL 60601 | |
| (c) | Citizenship:
Iliad Research and Trading, LP is a Utah limited partnership.
Iliad Management, LLC is a Delaware limited liability company.
Fife Trading, Inc. is an Illinois corporation.
John M. Fife is a United States citizen. | |
| (d) | Title of class of securities: Common Stock $0.00001 par value | |
| (e) | CUSIP No.: 14160X203 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o); | |
| (b) | Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); | |
| (c) | Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); | |
| (d) | Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); | |
| (e) | An
investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); | |
| (f) | An
employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); | |
| (g) | A
parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | |
| (h) | A
savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.
1813); | |
| (i) | A
church plan that is excluded from the definition of an investment company under section 3(c)(14)
of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | A
non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S.
institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: | |
| (k) | Group,
in accordance with Rule 240.13d-1(b)(1)(ii)(K). | |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned: 2,415,275 | |
| (b) | Percent of class: 9.99% % | |
| (c) | Number of shares as to which the person has: | |
| (i) Sole power to vote or to direct the vote: 2,415,275 | ||
| (ii) Shared power to vote or to direct the
vote: 0 | ||
| (iii) Sole power to dispose or to direct the
disposition of: 2,415,275 | ||
| (iv) Shared power to dispose or to direct the
disposition of: 0 | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
|
| SIGNATURE | |
After reasonable inquiry and to the
best of my knowledge and belief, I certify that the information set forth in this statement is
true, complete and correct. |
|
|
|
|
|
|
|
|